No Data
No Data
Wells Fargo Downgrades Zymeworks(ZYME.US) to Hold Rating, Raises Target Price to $14
Express News | Wells Fargo Maintains Equal-Weight on Zymeworks, Raises Price Target to $14
Biggest Stock Movers Tuesday: ZYME, EVGO, and More
Zymeworks Raised to Overweight From Neutral by JP Morgan
J.P. Morgan Upgrades Zymeworks(ZYME.US) to Buy Rating, Raises Target Price to $18
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
Unlock the Full List